Insensitive detection of low ER expression leading to immunohistochemical staining discrepancy and ESR mutation may cause decreased ligand-binding affinity, which could explain the emergence of single PR-positive breast cancer (32), while this subgroup still exists even after excluding these potential causes, and consistency of the recorded incidence confirm the presence of single PR-positive breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.